|
US5846983A
(en)
*
|
1996-02-09 |
1998-12-08 |
Mayo Foundation For Medical Education And Research |
Colonic delivery of nicotine to treat inflammatory bowel disease
|
|
AU752802C
(en)
*
|
1997-11-14 |
2006-04-13 |
Pacira Pharmaceuticals, Inc. |
Production of multivesicular liposomes
|
|
DK1065936T3
(da)
|
1998-03-23 |
2009-11-02 |
Gen Mills Inc |
Indkapsling af bestanddele i spiselige produkter
|
|
AUPP627498A0
(en)
|
1998-10-02 |
1998-10-22 |
University Of Queensland, The |
Novel peptides - i
|
|
DE19847715A1
(de)
*
|
1998-10-16 |
2000-04-20 |
Lohmann Therapie Syst Lts |
Verfahren zur Behandlung der Schizophrenie sowie Mittel zur Verwendung in diesem Verfahren
|
|
PT1225897E
(pt)
*
|
1999-11-01 |
2005-01-31 |
John Rhodes |
Composicao para o tratamento da obstipacao e do sindroma do intestino irritavel
|
|
US6468568B1
(en)
|
2000-06-16 |
2002-10-22 |
General Mills, Inc. |
Oligosaccharide encapsulated mineral and vitamin ingredients
|
|
US6436453B1
(en)
|
2000-06-16 |
2002-08-20 |
General Mills, Inc. |
Production of oil encapsulated minerals and vitamins in a glassy matrix
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
EP1325752A3
(en)
*
|
2000-08-03 |
2003-08-06 |
Antares Pharma IPL AG |
Composition for transdermal and/or transmucosal administration of active compounds which ensures adequate therapeutic levels
|
|
WO2005039531A1
(en)
|
2003-10-10 |
2005-05-06 |
Antares Pharma Ipl Ag |
Transdermal pharmaceutical formulation for minimizing skin residues
|
|
CA2341952A1
(en)
|
2001-03-23 |
2002-09-23 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
|
|
US7081475B2
(en)
|
2001-09-14 |
2006-07-25 |
Prolx Pharmaceuticals Corp. |
Wortmannin analogs and methods of using same
|
|
US20040037879A1
(en)
*
|
2001-11-02 |
2004-02-26 |
Adusumilli Prasad S. |
Oral controlled release forms useful for reducing or preventing nicotine cravings
|
|
US8039459B2
(en)
|
2004-07-15 |
2011-10-18 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory diseases
|
|
US8557804B2
(en)
|
2002-03-25 |
2013-10-15 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory diseases
|
|
SI1572725T1
(sl)
|
2002-12-02 |
2012-08-31 |
Xenome Ltd |
Hi-konotoksin peptidi, ki imajo N-terminalno piroglutaminsko kislino
|
|
EP2412719A1
(en)
|
2002-12-02 |
2012-02-01 |
Xenome Ltd |
Chi-conotoxin peptides
|
|
US8337891B2
(en)
|
2003-07-03 |
2012-12-25 |
Sucampo Ag |
Enteric coated composition comprising prostaglandin analogs as chloride channel opener
|
|
WO2005009386A2
(en)
|
2003-07-24 |
2005-02-03 |
Smithkline Beecham Corporation |
Orally dissolving films
|
|
JP5114631B2
(ja)
*
|
2003-09-01 |
2013-01-09 |
有限会社アーザス |
β−ヒドロキシ短〜中鎖脂肪酸重合体
|
|
US20070191815A1
(en)
|
2004-09-13 |
2007-08-16 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
|
EP1761265A2
(en)
*
|
2004-06-28 |
2007-03-14 |
ALZA Corporation |
A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
|
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
WO2006125642A1
(en)
*
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
|
KR20080066712A
(ko)
*
|
2005-09-30 |
2008-07-16 |
티티아이 엘뷰 가부시키가이샤 |
관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
|
|
JP2009509634A
(ja)
*
|
2005-09-30 |
2009-03-12 |
Ｔｔｉ・エルビュー株式会社 |
官能基化マイクロニードル経皮薬剤送達システム、装置及び方法
|
|
KR20080080087A
(ko)
*
|
2005-09-30 |
2008-09-02 |
티티아이 엘뷰 가부시키가이샤 |
신규 약학 담체를 이용한 경피 약물 전달시스템, 장치 및방법
|
|
US7803413B2
(en)
|
2005-10-31 |
2010-09-28 |
General Mills Ip Holdings Ii, Llc. |
Encapsulation of readily oxidizable components
|
|
CN101426475A
(zh)
|
2006-04-21 |
2009-05-06 |
安塔雷斯制药Ipl股份公司 |
使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
|
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
|
WO2008120778A1
(ja)
|
2007-03-30 |
2008-10-09 |
Earthus, Inc. |
ケトン体生成促進剤組成物
|
|
US7718677B2
(en)
*
|
2007-04-02 |
2010-05-18 |
Parkinson's Institute |
Methods and compositions for reduction of side effects of therapeutic treatments
|
|
RU2482841C2
(ru)
*
|
2007-05-18 |
2013-05-27 |
ТиТиАй Эллебо, Инк. |
Устройства для трансдермальной доставки, обеспечивающие улучшенное высвобождение действующего начала через биологическую поверхность
|
|
TW200948383A
(en)
*
|
2008-05-19 |
2009-12-01 |
Univ Nat Taiwan |
System for determining function of intestinal barrier
|
|
US20110268809A1
(en)
|
2010-04-28 |
2011-11-03 |
Paul Andrew Brinkley |
Nicotine-Containing Pharmaceutical Compositions
|
|
US20110274628A1
(en)
|
2010-05-07 |
2011-11-10 |
Borschke August J |
Nicotine-containing pharmaceutical compositions
|
|
ES2676343T3
(es)
*
|
2010-12-21 |
2018-07-18 |
Fertin Pharma A/S |
Composición de goma de mascar que comprende ácido poliacrílico reticulado
|
|
US20130017259A1
(en)
|
2011-07-06 |
2013-01-17 |
The Parkinson's Institute |
Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
|
|
US20130078307A1
(en)
|
2011-09-22 |
2013-03-28 |
Niconovum Usa, Inc. |
Nicotine-containing pharmaceutical composition
|
|
US9907748B2
(en)
|
2011-10-21 |
2018-03-06 |
Niconovum Usa, Inc. |
Excipients for nicotine-containing therapeutic compositions
|
|
US9763928B2
(en)
|
2012-02-10 |
2017-09-19 |
Niconovum Usa, Inc. |
Multi-layer nicotine-containing pharmaceutical composition
|
|
WO2013186355A1
(en)
*
|
2012-06-15 |
2013-12-19 |
Conaris Research Institute Ag |
A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
|
|
WO2014016653A1
(en)
|
2012-07-26 |
2014-01-30 |
Wockhardt Limited |
Pharmaceutical composition comprising diamorphine for intranasal administration
|
|
US20140255452A1
(en)
|
2013-03-11 |
2014-09-11 |
Niconovum Usa, Inc. |
Method and apparatus for differentiating oral pouch products
|
|
SG11201604759UA
(en)
|
2013-12-13 |
2016-07-28 |
Conaris Res Inst Ag |
A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation
|
|
ES2788866T3
(es)
|
2013-12-13 |
2020-10-23 |
Conaris Res Institute Ag |
Una composición farmacéutica que contiene ácido nicotínico y/o nicotinamida para su uso en influir beneficiosamente en los niveles de lípidos en sangre mediante la modificación de la microbiota intestinal
|
|
EP3154530B1
(en)
*
|
2014-06-10 |
2018-04-04 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Nanoparticulate complex of nicotine and cerium oxide and use thereof
|
|
CA2974324A1
(en)
|
2015-01-28 |
2016-08-04 |
Zita S. Netzel |
Drug delivery methods and systems
|
|
JP2018511127A
(ja)
|
2015-03-12 |
2018-04-19 |
クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
渇望入力及び支援システム
|
|
CA2997915A1
(en)
|
2015-09-15 |
2017-03-23 |
C.B. Fleet Company, Incorporated |
Bisacodyl compositions and delivery apparatus
|
|
US10532046B2
(en)
*
|
2015-12-03 |
2020-01-14 |
Niconovum Usa, Inc. |
Multi-phase delivery compositions and products incorporating such compositions
|
|
US20170165252A1
(en)
|
2015-12-10 |
2017-06-15 |
Niconovum Usa Inc. |
Protein-enriched therapeutic composition
|
|
US10143687B2
(en)
|
2016-04-11 |
2018-12-04 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
|
US10292977B2
(en)
|
2016-04-11 |
2019-05-21 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
|
WO2018113916A1
(en)
*
|
2016-12-20 |
2018-06-28 |
Fertin Pharma A/S |
A mucoadhesive oromucosal formulation comprising a nicotine complex
|
|
EP3565617A1
(en)
|
2017-01-06 |
2019-11-13 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
WO2019232077A1
(en)
|
2018-05-29 |
2019-12-05 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
|
EP3807260B1
(en)
|
2018-06-15 |
2024-09-18 |
R. J. Reynolds Tobacco Company |
Purification of nicotine
|
|
EP3880175A4
(en)
|
2018-11-16 |
2022-08-17 |
Morningside Venture Investments Limited |
TEMPERATURE-REGULATING TRANSDERMAL DRUG DELIVERY SYSTEM
|